Medscape September 28, 2022
WASHINGTON (Reuters) – U.S. President Joe Biden claimed victory on Tuesday for a drop in costs for tens of millions of Americans covered by the Medicare health program, though it is primarily due to a decision to severely limit coverage of an expensive, new Alzheimer’s drug.
Biden highlighted a drop in premiums next year for the first time in over a decade for Medicare Part B, which among other things covers doctor and hospital visits as well as drugs they administer. He said the result will be a saving of more than $60 a year per beneficiary.
“It’s going to be a godsend for many families,” Biden told healthcare advocates in a White House Rose Garden event.
“It’s going to...
Today's Sponsors
Today's Sponsor